DexCom’s Acquisition of TypeZero Technologies Marks First Exit For University of Virginia Licensing & Ventures Group Seed Fund
The University of Virginia Licensing & Ventures Group (UVA LVG) Seed Fund has exited from TypeZero Technologies, Inc. following the recent announcement of DexCom, Inc.’s acquisition of the company. DexCom, a publicly traded company, headquartered in San Diego, Calif., is the leader in continuous glucose monitoring for people with diabetes. TypeZero’s products include software for […]
Twelve Academic Technologies Selected for Science Center Proof-of-Concept Program
Twelve promising technologies developed at nine academic institutions across the tristate region have been selected as finalists for the University City Science Center’s QED Program. QED is designed to bridge the gap between academic research and product commercialization. Researchers from the Children’s Hospital of Philadelphia; Harrisburg University of Science and Technology; New Jersey Institute of Technology; Penn State College […]